DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Kohan DE, Fioretto P, Tang W. et al.
Long-term study of patients with type 2 diabetes and moderate renal impairment shows that dapagliflozin reduces weight and blood pressure but does not improve glycemic control.
Kidney Int 2014;
85: 962-971
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.